title: New varicella vaccines.
abstract: The live attenuated varicella vaccine, which is available for the prevention of chickenpox, was produced by a classic technology that also has been used for polio, measles, mumps, and rubella vaccines. There are many newer technologies that have been applied to the research and development of other vaccines. Each of these other approaches offers potential advantages and disadvantages relative to the current varicella vaccine.
authors.affiliation: Merck Research Laboratories, West Point, Pennsylvania, USA.
authors.forename: R W
authors.initials: RW
authors.lastname: Ellis
mesh_terms: D002644:Chickenpox / Q000517:prevention & control; D019433:Chickenpox Vaccine / Q000276:immunology / Q000627:therapeutic use*; D004279:DNA, Viral; D006562:Herpes Zoster / Q000517:prevention & control; D014645:Herpesvirus 3, Human / Q000235:genetics / Q000276:immunology; D006801:Humans; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic
chemical_list: D019433:Chickenpox Vaccine; D004279:DNA, Viral; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic